entertainment -WSS

entertainment

author：entertainment 2025-09-02 17:40:14 - browse：288

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Medicare wants to send $9 billion to 340B hospitals

leisure time

WSS

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Pennsylvania man bitten on the head by bear during attack in his garage

Swim instructor mom warns parents not to buy blue swimsuits for kids

Doctors are clamoring for more clarity on Paxlovid prescribing

It was time to plan for my old age. If only I could stop crying

Eisai exec who led development of Alzheimer’s drug to retire

focus

entertainment

focus

What does generative AI mean for health care? We asked experts

Teachers share how revamped forgiveness program helped with their student loans

In age of alternative facts, a scholarly course on calling out crap

Trump used to be more articulate. What could explain the change?

Hepatitis C has a cure — but many Americans still lack access to it

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

23andMe had bad news about my health. I wish a person had delivered it

Doctors are clamoring for more clarity on Paxlovid prescribing

Continuity nursing helped my family in our darkest PICU moments

The U.S. needs a new definition of substance use “recovery”

leisure time

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Feed a cold, starve a fever? Here’s what science says

Feed a cold, starve a fever? Here’s what science says

Biden targets hefty hospital 'facility fees' that often surprise patients

Kansas bar where gunfire wounded 9 last month closes permanently

ACA's risk program benefits Blue Cross Blue Shield insurers

leisure time

focus

leisure time

focus